Prostatic adenocarcinoma (PA) is the second most common malignancy in men globally. Signet-ring cell-like adenocarcinoma (SRCC) is a very rare PA subtype, with around 200 cases reported in the English literature. Histologically, the tumor cells show a vacuole compressing the nucleus to the periphery. Pagetoid spread in acini and ducts is usually related to metastases from urothelial or colorectal carcinomas, less commonly associated with intraductal carcinoma (IC); histologically, the tumor cells grow between the acinar secretory and basal cell layers. To our knowledge, we report the first prostatic SRCC (Gleason score 10, stage pT3b) associated with IC and pagetoid spread to prostatic acini and seminal vesicles. To our systematic literature review (PRISMA guidelines), it is the first tested case for both PD-L1 (<1% of positive tumor cells, clone 22C3) and mismatch repair system proteins (MMR) (MLH1+/MSH2+/PMS2+/MSH6+). We found no SRCC previously tested for MMR, while only four previous cases showed high expression of another PD-L1 clone (28-8). Finally, we discussed the differential diagnoses of prostatic SRCC.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303679 | PMC |
| http://dx.doi.org/10.3390/jpm13061016 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Urothelial carcinoma in situ with "early papillary formation" vs "lateral spread/shoulder lesion" of prior high-grade noninvasive papillary urothelial carcinoma: A survey of pathologist and urologist interpretations.
Am J Clin Pathol
December 2024
Department of Pathology and Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, OH, United States.
Objectives: Urothelial carcinoma in situ (CIS) with early papillary formation is terminology sometimes used to suggest incipient high-grade papillary urothelial carcinoma (PUC) but may lead to confusion between true CIS and lateral flat spread of PUC.
Methods: It remains unclear how pathologists and urologists interpret this scenario, so a survey was circulated to 68 pathologists (group 1 = 28 academic genitourinary pathologists; group 2 = 17 pathologists with a self-reported genitourinary focus; group 3 = 23 pathologists self-reported as not genitourinary specialists) and 32 urologists.
Results: Regarding atypical urothelial lesions that appear mainly flat but contain possible papillae, group 3 was more likely to label this as CIS compared with groups 1 and 2 (35% for group 3 vs 13% for groups 1 and 2), while groups 1 and 2 more often adopted another descriptive diagnosis, such as "CIS with early papillary features" (38% for groups 1 and 2 vs 13% for group 3).
Rectal Adenocarcinoma With Pagetoid Spread: A Novel Entity.
Case Rep Gastrointest Med
October 2024
Colorectal Surgery, St. Joseph's University Medical Center, Paterson, New Jersey, USA.
Perianal Paget's disease (PPD) is a rare skin adenocarcinoma that arises in the apocrine glands of the perianal region. It is often misdiagnosed as eczema, leukoplakia, squamous cell carcinoma, Bowen's disease, lichen planus, or condylomata acuminata. We report a case of a 63-year-old male who presented to the emergency room (ER) for evaluation of an anal mass that had persisted over 6 months.
View Article and Find Full Text PDFA case of pagetoid spread of urothelial carcinoma with notable reduction achieved through enfortumab vedotin, resulting in complete surgical resection.
Int Cancer Conf J
October 2024
Department of Urology, The Jikei University the 3rd, Hospital, 4-11-1, Izumihoncho, Komae-Shi, Tokyo, 201-8601 Japan.
Article Synopsis
- Secondary extramammary Paget's disease is a rare condition that occurs when tumor cells spread from nearby tissues, often linked to underlying cancers of the skin, genitourinary, or gastrointestinal tracts.
- An 80-year-old woman with a 7-year history of urothelial carcinoma developed a lesion on her labia majora, diagnosed as pagetoid spread of her carcinoma, but she chose not to have it surgically removed.
- After receiving several treatments, including platinum-based chemotherapy and pembrolizumab, her condition improved significantly with enfortumab vedotin, leading to a successful complete resection of the tumor.
Single-Cell RNA Profiling of Ocular Adnexal Sebaceous Carcinoma Reveals a Complex Tumor Microenvironment and Identifies New Biomarkers.
Am J Ophthalmol
October 2024
From the Dr. Nasser Ibrahim Al-Rashid Orbital Vision Research Center (M.G.Z., R.A.G., A.H.M., D.P., and A.J.R.), Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA; Sylvester Comprehensive Cancer Center (M.G.Z., R.A.G., D.P., and A.J.R.), University of Miami Miller School of Medicine, Miami, Florida, USA; Division of Oculofacial Plastic, Reconstructive, and Orbital Surgery (A.J.R.), Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA. Electronic address:
Article Synopsis
- Ocular adnexal sebaceous carcinoma (OaSC) is a severe eye cancer that requires removal of the eye and has not been well understood at the cellular level, prompting this study to investigate its genetic makeup for better treatment options.* -
- The researchers performed single-cell RNA sequencing on samples from six patients to explore the different cell types present, finding that OaSC tumors contain a mix of cancer, immune, and support cells, with certain gene pathways linked to cancer growth and spread being notably activated or suppressed.* -
- Key findings include the upregulation of CALML5 in OaSC tumors, which could serve as a potential biomarker, with evidence supporting its presence in every OaSC case
Eyelid and periocular sebaceous gland carcinoma: risk factors for recurrence, exenteration, metastasis, and death in 355 patients.
Can J Ophthalmol
October 2024
The Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India.
Article Synopsis
- The study looks at factors that can tell if a certain type of skin cancer, called eyelid and periocular sebaceous gland carcinoma (eSGC), will come back or spread in patients after treatment.
- Out of 355 patients studied, most hadn't had any treatment before coming to this research center. The treatments included surgeries, chemical therapy, and medications.
- Key factors that make the cancer more likely to return or spread included how the cancer looks, its size, if it spreads to nearby areas, and if there are positive margins in the tissue after surgery.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!